USANA announces CEO transition: Jim Brown to succeed Kevin Guest as CEO effective July 1, 2023

USANA HEALTH SCIENCES INC

Kevin Guest will transition to Executive Chairman; Jim Brown named CEO effective July 1, 2023.
Jim Brown has served as President since 2019, previously COO and Chief Production Officer.
Kevin Guest has been CEO since 2015 and Chairman since 2020; will remain involved as Executive Chairman.
Current compensation for both executives unchanged until July 1; new packages to be set by Compensation Committee.

item 5.02 item 7.01 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Jim Brown

Chief Executive Officer

USNA · USANA HEALTH SCIENCES INC

Effective: 2023-07-01
Filed: February 13, 2023, 6:59 PM ET

On February 13, 2023, USANA Health Sciences, Inc. (the “Company” or “USANA”) announced that its Board of Directors (the “Board”) has appointed Jim Brown as the Company’s Chief Executive Officer effective July 1, 2023

Role change

Kevin Guest

Executive Chairman

USNA · USANA HEALTH SCIENCES INC

Effective: 2023-07-01
Successor: Jim Brown
Filed: February 13, 2023, 6:59 PM ET

Mr. Brown will succeed Kevin Guest, who will transition to Executive Chairman of the Company on the Effective Date.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Jim Brown was appointed as Chief Executive Officer at USANA HEALTH SCIENCES INC.

Action: appointed
Role: Chief Executive Officer

Exact text from the filing

On February 13, 2023, USANA Health Sciences, Inc. (the “Company” or “USANA”) announced that its Board of Directors (the “Board”) has appointed Jim Brown as the Company’s Chief Executive Officer effective July 1, 2023

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.95

Kevin Guest changed role as Executive Chairman at USANA HEALTH SCIENCES INC.

Action: transition to
Role: Executive Chairman

Exact text from the filing

Mr. Brown will succeed Kevin Guest, who will transition to Executive Chairman of the Company on the Effective Date.

View on SEC.gov

USANA HEALTH SCIENCES INC filing history →

Source: SEC EDGAR

accession 0001157523-23-000267

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.